Kadcyla, a drug that can offer some women with advanced breast cancer nearly six months of extra life, which was trialled here in the North East, has for now been rejected for use in the NHS, because of its high cost.
A Newcastle doctor whose patients have been involved in the clinical trials is disappointed by the decision.
Dr Mark Verrill, from the Freeman Hospital, say the drug is revolutionary.
More top news
Researchers in the US believe they may be a step closer to finding Captain Cook's ship, the Endeavour.
A look ahead at the forecast for the Tyne Tees region
Northumbria police force is facing allegations of fostering a culture of "sexism" by a former employee.